The Epigenomics of Embryonic Pathway Signaling in Colorectal Cancer
Colorectal cancer (CRC) is the second-leading cause of cancer death in developed countries. While early detection (e.g., colonoscopy) generally yields excellent outcomes, metastatic and drug-resistant disease is uniformly fatal, and non-compliance for screening remains over 25%. Familial CRCs (10% o...
Main Authors: | Curt Balch, Jayaram B. Ramapuram, Amit K. Tiwari |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-05-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fphar.2017.00267/full |
Similar Items
-
Epithelial Mesenchymal Transition in Embryonic Development, Tissue Repair and Cancer: A Comprehensive Overview
by: Do Hyung Kim, et al.
Published: (2017-12-01) -
Nucleolar and Spindle Associated Protein 1 (NUSAP1) Promotes Bladder Cancer Progression Through the TGF-β Signaling Pathway
by: Gao S, et al.
Published: (2020-01-01) -
Curcumin reverses oxaliplatin resistance in human colorectal cancer via regulation of TGF-β/Smad2/3 signaling pathway
by: Yin J, et al.
Published: (2019-05-01) -
Tanshinone IIA Inhibits Epithelial-to-Mesenchymal Transition Through Hindering β-Arrestin1 Mediated β-Catenin Signaling Pathway in Colorectal Cancer
by: Qing Song, et al.
Published: (2020-10-01) -
RAS, Cellular Plasticity, and Tumor Budding in Colorectal Cancer
by: Valeria Maffeis, et al.
Published: (2019-11-01)